XML 65 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Operating Segments (Tables)
9 Months Ended
Sep. 30, 2013
Segment Reporting [Abstract]  
Reportable Segments Summarized Financial Information
Summarized financial information concerning our reportable segments is shown in the following table. Corporate & other includes corporate-related items not allocated to the reportable segments.
 
 
 
Three Months Ended 
 September 30,
 
Nine Months Ended 
 September 30,
 
 
2013
 
2012
 
2013
 
2012
 
 
(In thousands)
Net sales:
 
 
 
 
 
 
 
 
Polymer Solutions
 
$
224,320

 
$
216,992

 
$
663,410

 
$
692,139

Catalysts
 
226,042

 
251,201

 
695,433

 
773,867

Fine Chemistry
 
198,276

 
193,033

 
565,617

 
591,818

Total net sales
 
$
648,638

 
$
661,226

 
$
1,924,460

 
$
2,057,824

Segment operating profit:
 
 
 
 
 
 
 
 
Polymer Solutions
 
$
40,678

 
$
44,694

 
$
128,169

 
$
162,648

Catalysts
 
53,878

 
55,093

 
146,536

 
189,104

Fine Chemistry
 
43,894

 
48,336

 
120,349

 
142,403

Total segment operating profit
 
138,450

 
148,123

 
395,054

 
494,155

Equity in net income of unconsolidated investments:
 
 
 
 
 
 
 
 
Polymer Solutions
 
1,735

 
1,199

 
6,371

 
4,957

Catalysts
 
3,603

 
6,736

 
18,937

 
24,276

Fine Chemistry
 

 

 

 

Corporate & other
 

 

 

 

Total equity in net income of unconsolidated
 
 
 
 
 
 
 
 
investments
 
5,338

 
7,935

 
25,308

 
29,233

Net income attributable to noncontrolling interests:
 
 
 
 
 
 
 
 
Polymer Solutions
 
(916
)
 
(602
)
 
(4,118
)
 
(1,255
)
Catalysts
 

 

 

 

Fine Chemistry
 
(6,416
)
 
(4,373
)
 
(17,132
)
 
(11,577
)
Corporate & other
 

 

 

 
(20
)
Total net income attributable to noncontrolling
 
 
 
 
 
 
 
 
interests
 
(7,332
)
 
(4,975
)
 
(21,250
)
 
(12,852
)
Segment income:
 
 
 
 
 
 
 
 
Polymer Solutions
 
41,497

 
45,291

 
130,422

 
166,350

Catalysts
 
57,481

 
61,829

 
165,473

 
213,380

Fine Chemistry
 
37,478

 
43,963

 
103,217

 
130,826

Total segment income
 
136,456

 
151,083

 
399,112

 
510,556

Corporate & other
 
(8,785
)
 
(3,608
)
 
(38,328
)
 
(25,091
)
Restructuring and other charges, net(1)
 

 

 

 
(94,703
)
Interest and financing expenses
 
(9,496
)
 
(7,914
)
 
(22,335
)
 
(25,134
)
Other (expenses) income, net
 
(389
)
 
2,370

 
(6,295
)
 
1,564

Income tax expense
 
(27,274
)
 
(32,472
)
 
(74,916
)
 
(93,382
)
Net income attributable to Albemarle Corporation
 
$
90,512

 
$
109,459

 
$
257,238

 
$
273,810

 
(1)
See Note 13, “Restructuring and Other.”